Vasculitis Trial, Recruiting (NCT06460142)

Vasculitis Trial, Recruiting NCT06460142 Sponsor: University of Bonn Condition: Vasculitis

Printed from Voxsanity (voxsanity.com.au) — NCT06460142 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Vasculitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be over 18 years old and willing to sign a consent form agreeing to take part in the study.
You must have a confirmed diagnosis of Giant Cell Arteritis (GCA) or Polymyalgia Rheumatica (PMR), confirmed by your doctor using recognised medical classification standards, and you must have either been newly diagnosed within the last 3 days or had a return of symptoms (a "flare") within the last 3 days.

Who may not be able to join:

You may not be eligible if your kidneys are not working well enough — specifically if your kidney filtration rate is below 30 mL/min (confirm with trial site).
You may not be eligible if you have another medical condition (separate from GCA or PMR) that requires you to regularly or occasionally take steroid medications (such as prednisone or cortisone) by mouth or injection.
You may not be eligible if you have been diagnosed with another inflammatory joint or rheumatic disease alongside GCA or PMR.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Valentin S. Schäfer, Univ. Prof., Department of Rheumatology and Clinical Immunology, University Hospital Bonn

Phone: 0049 151 582 337 07

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06460142

Sponsor: University of Bonn

Phase: Not Applicable

Status: Recruiting

Condition: Vasculitis

Trial contact: 0049 151 582 337 07

More information: https://clinicaltrials.gov/study/NCT06460142

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be over 18 years old and willing to sign a consent form agreeing to take part in the study.
You must have a confirmed diagnosis of Giant Cell Arteritis (GCA) or Polymyalgia Rheumatica (PMR), confirmed by your doctor using recognised medical classification standards, and you must have either been newly diagnosed within the last 3 days or had a return of symptoms (a "flare") within the last 3 days.

Who may not be able to join:

You may not be eligible if your kidneys are not working well enough — specifically if your kidney filtration rate is below 30 mL/min (confirm with trial site).
You may not be eligible if you have another medical condition (separate from GCA or PMR) that requires you to regularly or occasionally take steroid medications (such as prednisone or cortisone) by mouth or injection.
You may not be eligible if you have been diagnosed with another inflammatory joint or rheumatic disease alongside GCA or PMR.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Bonn

Registry

ClinicalTrials.gov

Start date

1 September 2023

Est. completion

30 September 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Number of Participants with Detected Neuro-Ophthalmological Manifestations; Number of Participants with Detected Cardiac and Aortic Involvement; Changes in Immune Cell Phenotype; Changes in Cytokine Profiles; Levels of Siglec-9 in Blood; Levels of sVAP-1 in Blood

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov